| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.9 | 6e-05 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.003 |